InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

Current share price for GSS : $0.080 0.002 (2.56%)+

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Strategic Partnership with Tecan and Repado 22 Jul 2025 8:38AM $0.420 $0.080 fallen by 80.95%
$18 Notification of cessation of securities - GSS 30 Jun 2025 11:08AM $0.370 $0.080 fallen by 78.38%
$18 Change in substantial holding 16 Jun 2025 4:53PM $0.415 $0.080 fallen by 80.72%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 10:12AM $0.430 $0.080 fallen by 81.40%
$18 Notification of cessation of securities - GSS 28 Feb 2025 3:10PM $0.555 $0.080 fallen by 85.59%
$18 1H FY25 Market Update 26 Feb 2025 10:14AM $0.500 $0.080 fallen by 84%
$18 Positive Momentum For The First Half Result 26 Feb 2025 10:13AM $0.500 $0.080 fallen by 84%
$18 Half Yearly Report and Accounts 26 Feb 2025 10:12AM $0.500 $0.080 fallen by 84%
$18 1H FY25 Results and Investor Webinar Notification 25 Feb 2025 10:12AM $0.500 $0.080 fallen by 84%
$18 Appointment of Joint Company Secretary 3 Feb 2025 11:41AM $0.560 $0.080 fallen by 85.71%
$18 Appendix 3Y - Late Lodgement Notice 3 Feb 2025 8:27AM $0.620 $0.080 fallen by 87.10%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 9:24AM $0.620 $0.080 fallen by 87.10%
$18 Change of Director's Interest Notice 17 Dec 2024 8:31AM $0.640 $0.080 fallen by 87.50%
$18 Application for quotation of securities - GSS 17 Dec 2024 8:21AM $0.640 $0.080 fallen by 87.50%
$18 Notification regarding unquoted securities - GSS 9 Dec 2024 8:35AM $0.635 $0.080 fallen by 87.40%
$18 Notification of cessation of securities - GSS 27 Nov 2024 4:33PM $0.680 $0.080 fallen by 88.24%
$18 Application for quotation of securities - GSS 25 Nov 2024 4:49PM $0.700 $0.080 fallen by 88.57%
$18 $5m R&D Tax Incentive Received 22 Nov 2024 10:16AM $0.715 $0.080 fallen by 88.81%
$18 Final Director's Interest Notice 20 Nov 2024 5:27PM $0.700 $0.080 fallen by 88.57%
$18 AGM Results of Meeting 20 Nov 2024 2:24PM $0.700 $0.080 fallen by 88.57%
$18 2024 AGM Chairman's Address and CEO Presentation 20 Nov 2024 8:20AM $0.720 $0.080 fallen by 88.89%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 8:41AM $0.620 $0.080 fallen by 87.10%
$18 Notice of Annual General Meeting/Proxy Form 18 Oct 2024 4:02PM $0.655 $0.080 fallen by 87.79%
$18 Notification regarding unquoted securities - GSS 14 Oct 2024 8:29AM $0.580 $0.080 fallen by 86.21%
$18 Initial Director's Interest Notice - Jenny Harry 1 Oct 2024 8:44AM $0.665 $0.080 fallen by 87.97%

76 - 100 of 523 results

Page 4 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.